Table 2 Distribution of detailed regimens among MAC patients.

From: Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55

Category

Regimens

N = 2101

TBI-based

CY/TBI + CA

485 (23.1%)

 

CY/TBI

243 (11.6%)

 

CY/TBI + ETP

22 (1.0%)

 

others

70 (3.3%)

Chemo-based

FLU/BU4 + MEL

440 (20.9%)

 

FLU/BU4+lowTBI

283 (13.5%)

 

FLU/BU4 + MEL + CA

197 (9.4%)

 

FLU/BU4+lowTBI+CA

101 (4.8%)

 

BU/CY

64 (3.0%)

 

FLU/Bu4

63 (3.0%)

 

FLU/BU4 + CY

39 (1.9%)

 

others

94 (4.5%)

  1. CY cyclophosphamide, TBI total body irradiation, CA cytarabine, ETP etoposide, FLU fludarabine, BU busulfan, MEL melphalan, lowTBI low dose TBI.
Back to article page